Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories.
about
Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.Screening for Cushing's syndrome in obese patients.The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.Cushing's syndrome: Stepwise approach to diagnosis.Surgically correctable adrenal-dependent hypertension: a report of five casesVariability in laboratory parameters used for management of Cushing's syndrome.Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.An approach to the evaluation and treatment of Cushing's disease.Cushing's disease.Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature.Dynamic testing in Cushing's syndrome.An evidence-base for laboratory endocrinology?Pitfalls in the diagnosis of Cushing's syndrome.Cushing's syndrome in pregnancy: an overview.Drugs and HPA axis.Specificity of screening tests for Cushing's syndrome in an overweight and obese population.The diagnosis of Cushing's syndrome.Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction.Diagnosing endocrine hypertension: a practical approach.Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.Spectrum Effect and Spectrum Bias in the Screening Test Performance for Amnestic Mild Cognitive Impairment: What are the Clinical Implications?Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome.The low dose dexamethasone suppression test: effect of time of administration and dose.Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.Increased diagnostic probability of subclinical Cushing's syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus.Reliability of the diagnostic tests for Cushing's syndrome performed in a tertiary referral center.
P2860
Q31121920-99B2F6E0-B18D-4368-948A-00245918A244Q33626037-4D6C9E83-65BD-47B8-A534-CFA36438E1CEQ34760816-31CB2D60-11B5-4C9A-80CB-D7770CC6434DQ34794021-0F910D5F-D7F5-4BB5-938F-BC3B7AAF5F04Q35590917-5F6C4BCC-EEA5-469F-966C-3010F6D37692Q35990533-0C64D22E-8708-457C-82E4-134429032A0CQ36327131-FAE3BADF-CA65-4926-96A8-36A417B857B7Q36516174-CA5818EB-CA6E-45D6-8A1F-095C7696E325Q36605358-27DD835F-24BE-4C3A-802E-FEDC6063943FQ36640965-19972E1E-F223-4812-A025-D2C342C99A9BQ36700602-104D73E2-8864-4434-9E88-2334E4607076Q37011793-97A87583-C428-4254-A73A-843531ACB99AQ37020170-1767D8C3-316E-4476-9B2A-6A56C59E83D8Q37062023-1535C334-BF3D-41CA-8B0E-AA596D9D94D3Q37062060-CE502FAB-F0F0-4B8E-B60F-6D4CEE1B6F76Q37135438-75CD4D08-D6DD-4950-B431-CAB6589627C1Q37379514-6A16BB3D-E839-44A6-AEF5-A9E53CFE2BFDQ37785860-09AB062E-5E9C-4A37-9EF7-AEEA085B582CQ37967615-C073FC3A-DF2A-4A0F-A45C-3EB6F743D7C9Q39169128-3EF1CD67-E20D-4ABE-95C4-211D823A347CQ39337899-1A8A2D44-AE63-44AB-9FCD-BC8CA20799E9Q40827243-E4F26642-24CE-4DB5-BFFF-5B2369A68C8AQ41324796-07346A71-FD0B-402F-8798-45981C17C4ADQ42446999-8DE272F3-7BC7-4357-B145-8BC5A18B0823Q43284395-05F36C9B-3699-461E-B6C7-8DFB2239DE5EQ44005950-8ECC3C3F-4B02-45FE-8C0E-0AED6E9A0F59Q45120458-2DAC903D-32BE-4663-BFF8-4CCD457D0665Q45332911-DE9955D0-D745-45BD-BC5C-D611A4AF2A69Q46147572-9206C1DA-6BD6-47A1-ACC0-9D8DA63450EAQ46834685-7EC3A33B-33FE-4B54-B323-BC85A364D4A8Q50954002-67573193-72C5-40A4-8E78-C7E1BBC4FB3F
P2860
Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Evidence for the low dose dexa ...... for biochemistry laboratories.
@en
type
label
Evidence for the low dose dexa ...... for biochemistry laboratories.
@en
prefLabel
Evidence for the low dose dexa ...... for biochemistry laboratories.
@en
P2093
P1476
Evidence for the low dose dexa ...... for biochemistry laboratories.
@en
P2093
P304
P356
10.1177/000456329703400302
P478
34 ( Pt 3)
P577
1997-05-01T00:00:00Z